Patents by Inventor Mary Kate Hart

Mary Kate Hart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunogenic compositions and vaccines for Ebola
    Patent number: 7736656
    Abstract: Using CTL epitopes to the Ebola GP, NP, VP24, VP30, VP35 and VP40 virion proteins, a method and composition for use in inducing an immune response which is protective against infection with Ebola virus is described.
    Type: Grant
    Filed: February 28, 2005
    Date of Patent: June 15, 2010
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Mary Kate Hart, Gene Garrard Olinger, Jr., Michael Adam Bailey
  • IMMUNOGENIC COMPOSITIONS AND VACCINES FOR EBOLA
    Publication number: 20100034843
    Abstract: Using CTL epitopes to the Ebola GP, NP, VP24, VP30, VP35 and VP40 virion proteins, a method and composition for use in inducing an immune response which is protective against infection with Ebola virus is described.
    Type: Application
    Filed: February 28, 2005
    Publication date: February 11, 2010
    Inventors: Mary Kate Hart, Gene Garrard Olinger, JR., Michael Adam Bailey
  • Monoclonal antibodies and complementarity-determining regions binding to Ebola glycoprotein
    Patent number: 7335356
    Abstract: In this application are described Ebola GP monoclonal antibodies, epitopes recognized by these monoclonal antibodies, and the sequences of the variable regions of some of these antibodies. Also provided are mixtures of antibodies of the present invention, as well as methods of using individual antibodies or mixtures thereof for the detection, prevention, and/or therapeutical treatment of Ebola virus infections in vitro and in vivo.
    Type: Grant
    Filed: December 16, 2004
    Date of Patent: February 26, 2008
    Assignee: United States of America as represented by the Secretary of the Army
    Inventors: Mary Kate Hart, Julie Wilson
  • Monoclonal antibodies and complementarity-determining regions binding to Ebola glycoprotein
    Patent number: 6875433
    Abstract: In this application are described Ebola GP monoclonal antibodies, epitopes recognized by these monoclonal antibodies, and the sequences of the variable regions of some of these antibodies. Also provided are mixtures of antibodies of the present invention, as well as methods of using individual antibodies or mixtures thereof for the detection, prevention, and/or therapeutical treatment of Ebola virus infections in vitro and in vivo.
    Type: Grant
    Filed: August 23, 2002
    Date of Patent: April 5, 2005
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Mary Kate Hart, Julie Wilson
  • Prophylactic and therapeutic monoclonal antibodies
    Patent number: 6824778
    Abstract: In this application are described monoclonal antibodies which recognize E3 glycoprotein of alphavirus and epitopes recognized by these monoclonal antibodies. Also provided are mixtures of antibodies of the present invention, as well as methods of using individual antibodies or mixtures thereof for the detection, prevention, and/or therapeutical treatment of alphavirus infections in vitro and in vivo.
    Type: Grant
    Filed: April 22, 2002
    Date of Patent: November 30, 2004
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventor: Mary Kate Hart
  • Monoclonal antibodies and complementarity-determining regions binding to Ebola glycoprotein
    Publication number: 20040053865
    Abstract: In this application are described Ebola GP monoclonal antibodies, epitopes recognized by these monoclonal antibodies, and the sequences of the variable regions of some of these antibodies. Also provided are mixtures of antibodies of the present invention, as well as methods of using individual antibodies or mixtures thereof for the detection, prevention, and/or therapeutical treatment of Ebola virus infections in vitro and in vivo.
    Type: Application
    Filed: August 23, 2002
    Publication date: March 18, 2004
    Inventors: Mary Kate Hart, Julie Wilson
  • Prophylactic and therapeutic monoclonal antibodies
    Publication number: 20030099931
    Abstract: In this application are described monoclonal antibodies which recognize E3 glycoprotein of alphavirus and epitopes recognized by these monoclonal antibodies. Also provided are mixtures of antibodies of the present invention, as well as methods of using individual antibodies or mixtures thereof for the detection, prevention, and/or therapeutical treatment of alphavirus infections in vitro and in vivo.
    Type: Application
    Filed: April 22, 2002
    Publication date: May 29, 2003
    Inventor: Mary Kate Hart